Synapse - Find an Expert

33620 Results

Patient journey and quality of life (QOL) among diffuse-type TGCT in the US

Meeting Abstract

Bernthal, N. M.; Spierenburg, G.; van de Sande, M.; Healey, J. H.; Stacchiotti, S.; Bauer, S.; Gelderblom, H.; Staals, E.; Bastida, J. L.; Fronk, E. M.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16(+) cancers

Meeting Abstract

Burman, B.; Niu, J.; Leidner, R. S.; Wang, D.; Richardson, D. L.; Iacobucci, C.; Hwang, A.; Qing, X.; Matushansky, I.; Zamarin, D.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Characterization of chemotherapy-induced peripheral neuropathy (CIPN) using patient-reported outcomes (PRO) and quantitative sensory testing (QST)

Meeting Abstract

Bao, T.; Zhi, W. I.; Chen, C.; Baser, R. E.; Li, Q. S.; Panageas, K.; Harte, S.; Mao, J. J.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma

Meeting Abstract

Araujo, D. M.; Druta, M.; Agulnik, M.; D'Angelo, S. P.; Blay, J. Y.; Strauss, S. J.; Valverde, C.; Razak, A. R. A.; Van Winkle, E.; Trivedi, T.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Leveraging local expertise in stewardship, hospital epidemiology and public health to enrich postgraduate training in NYC

Meeting Abstract

Cowman, K.; Ostrowsky, B.; Seo, S.; Guo, Y.; Chen, V.; Bartash, R.; Nori, P.
Infection Control and Hospital Epidemiology (2020)

Fulltext@MSK | Save

Implementation of rapid molecular diagnostic tests and antimicrobial stewardship involvement in acute-care hospitals

Meeting Abstract

Kondo, M.; Simon, M.; Westblade, L.; Jenkins, S.; Babady, E.; Loo, A.; Calfee, D.
Infection Control and Hospital Epidemiology (2020)

Fulltext@MSK | Save

Characterization of cytokine release syndrome (CRS) and neurological events (NEs) in the phase I TRANSCEND NHL 001 trial of lisocabtagene maraleucel (liso-cel) for patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)

Meeting Abstract

Abramson, J. S.; Siddiqi, T.; Gordon, L. I.; Lunning, M. A.; Wang, M.; Arnason, J. E.; Mehta, A. N.; Purev, E.; Maloney, D. G.; Andreadis, C.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

HCRN GU15-215: A phase II trial of atezolizumab (atezo) and bevacizumab (bev) in cisplatin-ineligible patients (pts) with advanced/unresectable urothelial cancer (UC)

Meeting Abstract

Balar, A. V.; Funt, S. A.; Gupta, S.; Dudek, A. Z.; Boiles, A. R.; Vaena, D. A.; Kilari, D.; Rosenberg, J. E.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Combined OX40 agonist and PD-1 inhibitor immunotherapy improves the efficacy of vascular targeted photodynamic therapy in a urothelial tumor model